Business

Steven Ullman, the University of Miami's director at the Center for Health Management and Policy, discusses telehealth use during and following the pandemic, why patient and provider satisfaction varies, and policy predictions for 2024.  

The company announced the appointments of numerous individuals to its executive team and will use the funds to expand its partnerships and oncology platform.

As host of HIMSS AI in Healthcare Forum, Robert Havasy, senior director of the Personal Connected Health Alliance at HIMSS, discusses the cautious optimism and warnings he heard from speakers and attendees about AI technology and its progress.  

The company will use the funds to prepare for commercialization in the U.S., enhance its platform and seek FDA clearance for its VERAFEYE platform.

Naomi Fried, founder and CEO of PharmStars, discusses the company's fifth cohort focused on solving challenges in therapeutic delivery and the 11 startups graduated from its accelerator program, including Cellular Vehicles and ZiO Health.  

Leaders in digital health foresee investors having a high bar for funding in 2024, looking toward companies with proven modalities and a clear pathway to profitability.

The American Medical Association uses “augmented intelligence,” not “artificial intelligence,” as the tech is meant to support, not replace, people, said Dr. Jesse Ehrenfeld, president of the AMA. Still, new regulatory paradigms are needed.

Updesh Dosanjh, practice leader of technology solutions for lQVIA, discusses ensuring fairness while using AI in clinical trials, the value of digital twins and the necessity of building and consistently adapting frameworks around AI use.  

Also, BetterSpace in India has received pre-seed funding to develop mobile mental health games.

The California-based company will use the funds to expand its Whole Body Twin Technology, aimed at preventing and reversing metabolic disease.